These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10871849)

  • 21. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
    Kamijo T; van de Kamp E; Chong MJ; Zindy F; Diehl JA; Sherr CJ; McKinnon PJ
    Cancer Res; 1999 May; 59(10):2464-9. PubMed ID: 10344759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.
    Jackson MW; Lindstrom MS; Berberich SJ
    J Biol Chem; 2001 Jul; 276(27):25336-41. PubMed ID: 11297540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein.
    DiGiammarino EL; Filippov I; Weber JD; Bothner B; Kriwacki RW
    Biochemistry; 2001 Feb; 40(8):2379-86. PubMed ID: 11327858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
    Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
    Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.
    Esteller M; Cordon-Cardo C; Corn PG; Meltzer SJ; Pohar KS; Watkins DN; Capella G; Peinado MA; Matias-Guiu X; Prat J; Baylin SB; Herman JG
    Cancer Res; 2001 Apr; 61(7):2816-21. PubMed ID: 11306450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.
    Sugimoto M; Kuo ML; Roussel MF; Sherr CJ
    Mol Cell; 2003 Feb; 11(2):415-24. PubMed ID: 12620229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.
    Rizos H; Puig S; Badenas C; Malvehy J; Darmanian AP; Jiménez L; Milà M; Kefford RF
    Oncogene; 2001 Sep; 20(39):5543-7. PubMed ID: 11571653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG
    Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma.
    Ho GH; Calvano JE; Bisogna M; Abouezzi Z; Borgen PI; Cordón-Cardó C; van Zee KJ
    Breast Cancer Res Treat; 2001 Feb; 65(3):225-32. PubMed ID: 11336244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.
    Xirodimas DP; Chisholm J; Desterro JM; Lane DP; Hay RT
    FEBS Lett; 2002 Sep; 528(1-3):207-11. PubMed ID: 12297306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a cryptic nucleolar-localization signal in MDM2.
    Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
    Nat Cell Biol; 2000 Mar; 2(3):179-81. PubMed ID: 10707090
    [No Abstract]   [Full Text] [Related]  

  • 36. The ARF tumour suppressor.
    Gallagher SJ; Kefford RF; Rizos H
    Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function.
    David-Pfeuty T; Nouvian-Dooghe Y
    Oncogene; 2002 Oct; 21(44):6779-90. PubMed ID: 12360404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
    Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.